机构ID,机构名称,公告日期,开始日期,截止日期,报告年度,合并类型,报表来源,销售商品、提供劳务收到的现金（元）,收到的税费返还,收到其他与经营活动有关的现金,经营活动现金流入小计,购买商品、接受劳务支付的现金,支付给职工以及为职工支付的现金,支付的各项税费,支付其他与经营活动有关的现金,经营活动现金流出小计,经营活动产生的现金流量净额,收回投资收到的现金,取得投资收益收到的现金,处置固定资产、无形资产和其他长期资产收回的现金净额,处置子公司及其他营业单位收到的现金净额,收到其他与投资活动有关的现金,投资活动现金流入小计,购建固定资产、无形资产和其他长期资产支付的现金,投资支付的现金,质押贷款净增加额,取得子公司及其他营业单位支付的现金净额,支付其他与投资活动有关的现金,投资活动现金流出小计,投资活动产生的现金流量净额,吸收投资收到的现金,取得借款收到的现金,发行债券收到的现金,收到其他与筹资活动有关的现金,筹资活动现金流入小计,偿还债务支付的现金,分配股利、利润或偿付利息支付的现金,支付其他与筹资活动有关的现金,筹资活动现金流出小计,筹资活动产生的现金流量净额,四、汇率变动对现金的影响,四(2)、其他原因对现金的影响,五、现金及现金等价物净增加额,期初现金及现金等价物余额,期末现金及现金等价物余额,附注：,1、将净利润调节为经营活动现金流量：,净利润,加：资产减值准备,固定资产折旧、油气资产折耗、生产性生物资产折旧,无形资产摊销,长期待摊费用摊销,处置固定资产、无形资产和其他长期资产的损失,固定资产报废损失,公允价值变动损失,财务费用,投资损失,递延所得税资产减少,递延所得税负债增加,存货的减少,经营性应收项目的减少,经营性应付项目的增加,其他,经营活动产生的现金流量净额2,2、不涉及现金收支的重大投资和筹资活动：,债务转为资本,一年内到期的可转换公司债券,融资租入固定资产,3、现金及现金等价物净变动情况：,现金的期末余额,减：现金的期初余额,加：现金等价物的期末余额,减：现金等价物的期初余额,加：其他原因对现金的影响2,现金及现金等价物净增加额2,客户存款和同业存放款项净增加额,向中央银行借款净增加额,向其他金融机构拆入资金净增加额,收到原保险合同保费取得的现金,收到再保险业务现金净额,保户储金及投资款净增加额,处置以公允价值计量且其变动计入当期损益的金融资产净增加额,收取利息、手续费及佣金的现金,拆入资金净增加额,回购业务资金净增加额,客户贷款及垫款净增加额,存放中央银行和同业款项净增加额,支付原保险合同赔付款项的现金,支付利息、手续费及佣金的现金,支付保单红利的现金,其中：子公司吸收少数股东投资收到的现金,其中：子公司支付给少数股东的股利、利润,投资性房地产的折旧及摊销
300558,贝达药业,2016-10-19,2016-01-01,2016-06-30,2016-06-30,合并本期,招募说明书,600591647.14,0.0,52027322.98,652618970.12,43299600.06,102751435.63,116209497.62,174270537.08,436531070.39,216087899.73,529837016.42,0.0,457048.91,5543756.13,6000000.0,541837821.46,121113450.07,788000000,,,,909113450.07,-367275628.61,0.0,,,0.0,,15000000.0,1155153.61,0.0,16155153.61,-16155153.61,254105.98,,-167088776.51,260105801.52,93017025.01,,,211893628.01,59155.24,4976185.58,4688466.74,468398.54,463878.82,,,1907189.58,-3604686.04,-773252.75,35510.19,-21131086.51,-7565249.5,16525773.84,8143987.99,216087899.73,,,,,,93017025.01,260105801.52,,,,-167088776.51,,,,,,,,,,,,,,,,,,
300558,贝达药业,2016-11-04,2016-01-01,2016-09-30,2016-09-30,合并本期,上市公告书,908395746.5,1649887.0,73862536.24,983908169.74,64959274.35,153318344.9,176503092.01,265124040.28,659904751.54,324003418.2,986927554.09,0.0,457048.91,5543756.13,6000000.0,998928359.13,174119467.44,1308000000,,,,1482119467.44,-483191108.31,0.0,,,0.0,,15000000.0,4074959.72,20033400.0,39108359.72,-39108359.72,345425.28,,-197950624.55,260105801.52,62155176.97,,,,,0.0,,0.0,,,,0.0,,,,,,,0.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
300558,贝达药业,2017-04-06,2016-01-01,2016-12-31,2016-12-31,合并本期,定期报告,1200532533.75,2197732.83,68483965.55,1271214232.13,40167814.49,202907131.14,231269655.89,389816611.69,864161213.21,407053018.92,1409904794.03,,466854.73,5543756.13,6628000.0,1422543404.89,294500443.91,2169250640,,,,2463751083.91,-1041207679.02,657350000.0,,,25621411.5,682971411.5,100400000.0,4558490.45,52027500.0,156985990.45,525985421.05,2013059.13,,-106156179.92,260105801.52,153949621.6,,,367864764.4,1214069.59,10023287.88,9376933.42,682425.14,464387.59,,,1941430.19,-4722417.5,-1006558.58,112467.7,-27822429.44,-15373096.68,52790318.94,11507436.27,407053018.92,,,,,,153949621.6,260105801.52,,,,-106156179.92,,,,,,,,,,,,,,,,,,
300558,贝达药业,2017-04-27,2017-01-01,2017-03-31,2017-03-31,合并本期,定期报告,267444411.3,,27201625.95,294646037.25,15093270.13,75582563.55,36844707.72,97005811.87,224526353.27,70119683.98,439133644.44,,120300.0,,,439253944.44,108394019.72,149994000,,,,258388019.72,180865924.72,,,,,,,,10383446.5,10383446.5,-10383446.5,-41560.28,,240560601.92,153921641.42,394482243.34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
300558,贝达药业,2017-08-22,2017-01-01,2017-06-30,2017-06-30,合并本期,定期报告,531438740.75,2258.75,33127071.77,564568071.27,27691946.95,122130067.3,96775194.74,206720999.29,453318208.28,111249862.99,1006449454.03,,120300.0,,,1006569754.03,229120760.94,234316500,,447819519.01,,911256779.95,95312974.08,,101616000.0,,,101616000.0,,72180000.0,130621411.5,202801411.5,-101185411.5,-1003297.92,,104374127.65,153949621.6,258323749.25,,,135268923.52,-934991.87,15311631.91,5084842.81,142684.6,108881.82,363.25,,179274.1,-8354462.68,271778.35,-39843.58,-14343949.13,-160079950.41,138634680.3,,111249862.99,,,,,,258323749.25,153949621.6,,,,104374127.65,,,,,,,,,,,,,,,,,,
